Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 26 (KRT8P26) is a member of the large family of keratin-derived pseudogenes found dispersed throughout the human genome[1][2]. It is a non-functional, processed pseudogene that originates from the keratin 8 gene (KRT8), a type II intermediate filament protein that is important in the structural integrity of epithelial cells[3][8]. However, KRT8P26 does not encode protein and is not actively involved in molecular, cellular, or disease processes. Its nomenclature is consistent with the designation system for human keratin pseudogenes. There is no evidence supporting a role for KRT8P26 in therapy, disease, or as a pharmacological/interventional target[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 26 (KRT8P26).